Literature DB >> 17094104

The ups and downs of alpha-synuclein mRNA expression.

Justus C Dächsel, Sarah J Lincoln, John Gonzalez, Owen A Ross, Dennis W Dickson, Matthew J Farrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17094104     DOI： 10.1002/mds.21223

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  18 in total

1.  Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.

Authors:  George K Tofaris; Hyoung Tae Kim; Raphael Hourez; Jin-Woo Jung; Kwang Pyo Kim; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-27       Impact factor: 11.205

2.  Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Authors:  Katerina Markopoulou; Joanna M Biernacka; Sebastian M Armasu; Kari J Anderson; J Eric Ahlskog; Bruce A Chase; Sun Ju Chung; Julie M Cunningham; Matthew Farrer; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2014-03-05       Impact factor: 4.891

3.  Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

Authors:  Robert J Phillips; Gary C Walter; Brittany E Ringer; Katherine M Higgs; Terry L Powley
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

4.  Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of α-Synuclein in Primary Neuronal Cultures and in Vivo.

Authors:  Georgia Dermentzaki; Nikolaos Paschalidis; Panagiotis K Politis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

Review 5.  Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Authors:  Masayuki Nakamori; Eunsung Junn; Hideki Mochizuki; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 6.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

7.  CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

Authors:  Lumine Matsumoto; Hiroshi Takuma; Akira Tamaoka; Hiroshi Kurisaki; Hidetoshi Date; Shoji Tsuji; Atsushi Iwata
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

8.  ATP13A2 variability in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alexandra I Soto; Sarah J Lincoln; Samia Ben Yahmed; Mounir Kefi; Michael G Heckman; Mary M Hulihan; Hua Chai; Nancy N Diehl; Rim Amouri; Alex Rajput; Deborah C Mash; Dennis W Dickson; Lefkos T Middleton; Rachel A Gibson; Faycal Hentati; Matthew J Farrer
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Genomic investigation of alpha-synuclein multiplication and parkinsonism.

Authors:  Owen A Ross; Adam T Braithwaite; Lisa M Skipper; Jennifer Kachergus; Mary M Hulihan; Frank A Middleton; Kenya Nishioka; Julia Fuchs; Thomas Gasser; Demetrius M Maraganore; Charles H Adler; Lydie Larvor; Marie-Christine Chartier-Harlin; Christer Nilsson; J William Langston; Katrina Gwinn; Nobutaka Hattori; Matthew J Farrer
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

10.  Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues.

Authors:  Colton Linnertz; Laura Saucier; Dongliang Ge; Kenneth D Cronin; James R Burke; Jeffrey N Browndyke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.